It was further determined that treatment of T2DM played a significant role in the risk of developing dementia, where oral anti-diabetic medication showed the lowest risk, followed by non-pharmacologically treated and insulin-dependent patients. Obesity only played a significant role in the insulin-dependent diabetic population. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.